Literature DB >> 11406118

Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat.

S Kastenbauer1, M Klein, U Koedel, H W Pfister.   

Abstract

Sensorineural hearing damage is a frequent complication of bacterial meningitis, affecting as many as 30% of survivors of pneumococcal meningitis. There is a substantial body of evidence that oxidants, such as reactive nitrogen species (RNS), are central mediators of brain damage in experimental bacterial meningitis. In the present study, we investigated whether RNS also contribute to the pathophysiology of suppurative labyrinthitis in our well-established rat model of pneumococcal meningitis. In all infected rats, but not in uninfected controls, we observed suppurative labyrinthitis. Cochlear inflammation was accompanied by severe blood-labyrinth barrier (BLB) disruption as evidenced by increased Evans Blue extravasation. Furthermore, increased cochlear expression of endothelial nitric oxide synthase (eNOS) and inducible nitric oxide synthase (iNOS) was detected by immunohistochemistry. Colocalization of iNOS and tyrosine nitration (a marker of RNS attack) indicated that nitric oxide (NO) produced by iNOS contributes to oxidative cochlear damage through the action of RNS. To determine the pathophysiological role of RNS in BLB disruption, rats were treated with peroxynitrite scavengers (MnTBAP and uric acid, UA). Six h after adjunctive treatment with 300 mg/kg i.p. UA or 15 mg/kg i.p. MnTBAP+100 mg/kg i.p. ceftriaxone, BLB disruption was significantly reduced compared with that in infected animals treated only with ceftriaxone. Therefore, we conclude that RNS are involved in the breaching of the BLB during meningogenic pneumococcal labyrinthitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11406118     DOI: 10.1016/s0006-8993(01)02164-3

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  13 in total

1.  Increased signal intensity of the cochlea on pre- and post-contrast enhanced 3D-FLAIR in patients with vestibular schwannoma.

Authors:  Masahiro Yamazaki; Shinji Naganawa; Hisashi Kawai; Takashi Nihashi; Hiroshi Fukatsu; Tsutomu Nakashima
Journal:  Neuroradiology       Date:  2009-12       Impact factor: 2.804

2.  Systemic lipopolysaccharide compromises the blood-labyrinth barrier and increases entry of serum fluorescein into the perilymph.

Authors:  Keiko Hirose; Jared J Hartsock; Shane Johnson; Peter Santi; Alec N Salt
Journal:  J Assoc Res Otolaryngol       Date:  2014-06-21

3.  Endolymphatic sac involvement in bacterial meningitis.

Authors:  Martin Nue Møller; Christian Brandt; Christian Østergaard; Per Caye-Thomasen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-01-23       Impact factor: 2.503

Review 4.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

5.  Pneumococcal meningitis: development of a new animal model.

Authors:  Benjamin P C Wei; Robert K Shepherd; Roy M Robins-Browne; Graeme M Clark; Stephen J O'Leary
Journal:  Otol Neurotol       Date:  2006-09       Impact factor: 2.311

Review 6.  Delivery of therapeutics to the inner ear: The challenge of the blood-labyrinth barrier.

Authors:  Sophie Nyberg; N Joan Abbott; Xiaorui Shi; Peter S Steyger; Alain Dabdoub
Journal:  Sci Transl Med       Date:  2019-03-06       Impact factor: 17.956

Review 7.  [N-acetyl-L-cysteine as a therapeutic option in bacterial meningitis].

Authors:  M Klein; U Koedel; H W Pfister
Journal:  Nervenarzt       Date:  2007-02       Impact factor: 1.214

Review 8.  Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria.

Authors:  Guy C Brown; Anna Bal-Price
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

9.  The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis.

Authors:  Michael Perny; Marta Roccio; Denis Grandgirard; Magdalena Solyga; Pascal Senn; Stephen L Leib
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

10.  Adjunctive N-acetyl-L-cysteine in treatment of murine pneumococcal meningitis.

Authors:  Tobias Högen; Cornelia Demel; Armin Giese; Barbara Angele; Hans-Walter Pfister; Uwe Koedel; Matthias Klein
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.